Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term study

Journal:

European Heart Journal

Published:

2026-03-05

DOI:

10.1093/eurheartj/ehaf1085

Affiliations:

19

Authors:

22

Go to article

Institutions	Authors	Share
Cytokinetics, United States of America (USA)	8.000000	0.36
Massachusetts General Hospital (MGH), United States of America (USA)	1.000000	0.05
Oregon Health and Science University (OHSU), United States of America (USA)	1.000000	0.05
University of California, San Francisco (UCSF), United States of America (USA)	1.000000	0.05
Northwestern University (NU), United States of America (USA)	1.000000	0.05
Liverpool John Moores University (LJMU), United Kingdom (UK)	1.000000	0.05
Lahey Hospital and Medical Center, United States of America (USA)	1.000000	0.05
National Institute of Cardiology, Poland	1.000000	0.05
University of Pennsylvania (Penn), United States of America (USA)	1.000000	0.05
Brigham and Women's Hospital (BWH), United States of America (USA)	1.000000	0.05
University of Michigan (U-M), United States of America (USA)	1.000000	0.05
University of Missouri-Kansas City (UMKC), United States of America (USA)	0.500000	0.02
Saint Luke’s Mid America Heart Institute, United States of America (USA)	0.500000	0.02
Institute of Biomedical Research of A Coruña (INIBIC), Spain	0.500000	0.02
Biomedical Research Networking Centers (CIBER), Spain	0.500000	0.02
Barts Heart Centre, United Kingdom (UK)	0.500000	0.02
UCL, United Kingdom (UK)	0.500000	0.02
IRCCS Meyer Children's Hospital, Italy	0.500000	0.02
Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Italy	0.500000	0.02

Interested in Cardiovascular Medicine and Haematology?